You can think of the incretin effect as a relay race that your hormones tag team
In preclinical studies, ALCAR reduced oxidative damage markers (lipid peroxidation, oxidized nucleotides, nitrotyrosine) in aged rat brains, while LCAR did not, despite both compounds similarly increasing ambulatory activity and tissue carnitine levels.[5] ALCAR also decreased infarction size in stroke models, whereas LCAR showed no protective effect in vivo, though both were neuroprotective in vitro.[6] These differences likely reflect ALCARs ability to donate acetyl groups for acetylcholine synthesis, energy production, and neurotransmitter metabolism.[2][7] For cardiovascular and metabolic applications, the compounds appear more comparable
It more comprehensively improves systemic oxidative stress
We further performed the following supplementary analyses: The 1year probability of having a biomarker measurement during followup was calculated as the number of patients with a measurement within x days after the index date divided by the number of patients at risk at that particular date
Dose-response and pharmacokinetics Research to characterize absorption, distribution, metabolism, and excretion in reproductive organs, as well as safe dose ranges and optimal delivery routes for focused targeting of gonadal tissue without systemic exposure
Still, certain factors, including specific medications, can produce false positive results
